Search keyWord:

Meizu's Mr. Gu Binbin at MWC25: Meizu is Back to Global Market with Flyme AI Ecosystem

BARCELONA,Spain,March 5,2025-- Meizu has marked its back to global market at MWC in Barcelona. In exclusive interactions with several media outlets,Mr. Gu Binbin,the executive director of overseas bus

Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director

ROCKVILLE,Md.,March 5,2025-- Ascend Advanced Therapies (Ascend),a gene to GMP advanced therapy development partner,today announced the appointment of John Chiminski and Karen Flynn as non-executive m

A new report by McKinsey & Company and the World Federation of the Sporting Goods Industry explores the state of the industry and growth themes for 2025 and beyond

HOW SPORTING GOODS BRANDS CAN TURN UNCERTAINTY INTO OPPORTUNITY BERN,Switzerland,March 5,2025-- McKinsey & Company and the World Federation of the Sporting Goods Industry (WFSGI) are pleased to an

Beyond Music Acquires Copyright Stake in BTS Hit Song "Butter"

SEOUL,South Korea,March 5,2025-- Beyond Music,Asia\'s leading music intellectual properties (IPs) investment and data management company,has acquired a copyright stake in "Butter," the globa

Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients

PALMA DE MALLORCA,Spain,March 5,2025-- LaminarPharma,a leader in the development of innovative cancer therapy based on membrane lipid therapy,announced today optimistic results from its ongoing clini

China Unicom open the new 5G-A era

China Unicom Unveils AI Home Cloud and the “Tone” Agent at MWC in Barcelona Ushering in a New Chapter

Pulnovo Medical Announces Closing of Nearly $100 Million Series C Financing

SHANGHAI,March 3,2025-- Pulnovo Medical,a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF),has announced the closing of nearly $100 million Series

Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma

SAN FRANCISCO andSUZHOU,China,March 3,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures,and commercializes high-qua

CARsgen's Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA

SHANGHAI,March 3,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors